Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001929354-23-000003

10% owner bought 25,000 shares at an average $2.95 ($73,874)

From the SEC's structured data for this filing

Trades in this filing

Caissa Capital Management ltd. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-17 Purchase : show line 1 in the form +15,000 $2.96 $44,436 1,282,700 I
2023-04-18 Purchase : show line 2 in the form +10,000 $2.94 $29,438 1,292,700 I
Open-market purchases · 25,000 sh · avg $2.95 · $73,874
Loading xslF345X04/primary_doc.xml…